Clinical trial
A Randomised, Controlled, Open-Label, Phase II-III Trial to Evaluate the Safety and Efficacy of Regimens Containing Bedaquiline and Pretomanid for the Treatment of Adult Patients With Pulmonary Multidrug Resistant Tuberculosis
NCT02589782 is registered in ClinicalTrials.gov with Medecins Sans Frontieres, Netherlands as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomised, Controlled, Open-Label, Phase II-III Trial to Evaluate the Safety and Efficacy of Regimens Containing Bedaquiline and Pretomanid for the Treatment of Adult Patients With Pulmonary Multidrug Resistant Tuberculosis
- Lead sponsor
- Medecins Sans Frontieres, Netherlands
- Phase
- Phase 2/3
- Overall status
- Completed
- Start date
- January 31, 2017
- Completion date
- August 5, 2022
- Enrollment
- 552 (actual)
- Sites
- 7
Conditions
As the registry lists them; a condition with its own page is linked.